Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.4568
+0.0178 (4.05%)
At close: Apr 23, 2025, 4:00 PM
0.3805
-0.0763 (-16.70%)
Pre-market: Apr 24, 2025, 4:29 AM EDT

Psyence Biomedical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22
Selling, General & Admin
2.791.81.632.15
Research & Development
0.430.951.610.17
Operating Expenses
3.222.753.232.32
Operating Income
-3.22-2.75-3.23-2.32
Interest Expense
-0.03-0.05--
Interest & Investment Income
000-
Currency Exchange Gain (Loss)
0.11-00.03-0
Other Non Operating Income (Expenses)
1.030.57--
EBT Excluding Unusual Items
-2.1-2.23-3.21-2.32
Other Unusual Items
-44.49-48.93--
Pretax Income
-46.59-51.16-3.21-2.32
Net Income
-46.59-51.16-3.21-2.32
Net Income to Common
-46.59-51.16-3.21-2.32
Shares Outstanding (Basic)
100-
Shares Outstanding (Diluted)
100-
Shares Change (YoY)
239.30%30.34%--
EPS (Basic)
-76.91-588.74-48.10-
EPS (Diluted)
-76.91-588.74-48.10-
Free Cash Flow
-2.89-2.95-1.59-1.74
Free Cash Flow Per Share
-4.76-33.96-23.88-
EBITDA
--2.75--
D&A For EBITDA
-0--
EBIT
-3.22-2.75-3.23-2.32
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q